Targeted T-cell Therapy Beneficial in Rare Form of Melanoma – Medscape

1. Targeted T-cell Therapy Beneficial in Rare Form of Melanoma  Medscape
2. Eyes Widen for Uveal Melanoma Treatment: Sapna Patel’s Groundbreaking Findings at ESMO 2025  CU Anschutz newsroom
3. Immatics (IMTX) Is Up 8.6% After Strong Anzu-cel Trial Data in Metastatic Uveal Melanoma—Has the Bull Case Changed?  simplywall.st
4. ESMO 25: Immatics Makes An Impact With Stellar Rare Eye Cancer Data  Citeline News & Insights
5. Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer  MedPage Today

Continue Reading